<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00182390</url>
  </required_header>
  <id_info>
    <org_study_id>CTMG-2001-PINT</org_study_id>
    <secondary_id>CIHR MCT-41549</secondary_id>
    <secondary_id>CIHR MCT-58455</secondary_id>
    <nct_id>NCT00182390</nct_id>
  </id_info>
  <brief_title>Premature Infants in Need of Transfusion (PINT)</brief_title>
  <official_title>A Randomized Controlled Trial of Two Hemoglobin Thresholds for Transfusion in Newborns &lt;1000g Birth Weight</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <brief_summary>
    <textblock>
      Hypothesis: That a high hemoglobin threshold for transfusion in extremely low birth weight
      (ELBW) infants is associated with a lower rate of survival without severe morbidity (defined
      as one or more of retinopathy of prematurity, bronchopulmonary dysplasia, or periventricular
      leukomalacia/ventriculomegaly).

      Primary Objective: To determine whether either a liberal or more restrictive threshold of
      hemoglobin level for red cell transfusion in ELBW infants is safer, by randomizing to either
      a high transfusion hemoglobin threshold or a low transfusion hemoglobin threshold.

      Follow-up at a corrected age of 18 months represents a conventional age at which to first
      assess neurodevelopmental outcomes, and to predict long-term outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2001</start_date>
  <completion_date type="Actual">November 2005</completion_date>
  <primary_completion_date type="Actual">February 2003</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Combined mortality or survival to tertiary hospital discharge without severe morbidity (BPD, severe ROP or brain injury)</measure>
    <time_frame>neonatal phase</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Combined mortality or survival with neurodevelopmental disability (non-ambulatory cerebral palsy, blindness, deafness, cognitive delay)</measure>
    <time_frame>follow-up phase 18 months corrected age</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>growth in weight and head circumference</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to extubation</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time on oxygen</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay until discharge home</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>confirmed necrotizing enterocolitis</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>apnea requiring treatment</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>culture-proven infections</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>use of post-natal steroids</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean levels of hemoglobin</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of transfusions</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of donor exposures</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum ferritin levels</measure>
    <time_frame>neonatal phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>milder forms of cerebral palsy</measure>
    <time_frame>follow-up phase 18 months corrected age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>milder neurologic disorder</measure>
    <time_frame>follow-up phase 18 months corrected age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>personal and social functional capabilities</measure>
    <time_frame>follow-up phase 18 months corrected age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hydrocephalus requiring a shunt</measure>
    <time_frame>follow-up phase 18 months corrected age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>seizure disorder</measure>
    <time_frame>follow-up phase 18 months corrected age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory disease</measure>
    <time_frame>follow-up phase 18 months corrected age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>iron nutritional status</measure>
    <time_frame>follow-up phase 18 months corrected age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical growth including head size</measure>
    <time_frame>follow-up phase 18 months corrected age</time_frame>
  </secondary_outcome>
  <enrollment>424</enrollment>
  <condition>Anemia of Prematurity</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Red blood cell transfusion</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  birth weight &lt;1000g

          -  postnatal age &lt;48 hours

          -  no transfusion beyond first 6 hours of life

          -  estimated gestational age of 30 completed weeks or less

        Exclusion Criteria:

          -  infant considered non-viable by attending physician

          -  infant has cyanotic congenital heart disease

          -  infant's parents known to be opposed to blood transfusion

          -  either parent has hemoglobinopathies or congenital anemias

          -  infant has hemolytic disease

          -  infant has severe acute hemorrhage, severe shock, severe sepsis with coagulopathy or
             requires peri-operative transfusion

          -  prior treatment with or intention to treat with erythropoietin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>48 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haresh Kirpalani, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robin K Whyte, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dalhousie University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robin S Roberts, MTech</last_name>
    <role>Study Director</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elizabeth Asztalos, MD, MSc</last_name>
    <role>Study Director</role>
    <affiliation>Sunnybrook &amp; Women's College Health Sciences Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chad Andersen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mercy Hospital for Women</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Morris Blajchman, PhD</last_name>
    <role>Study Director</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nancy Heddle, MSc</last_name>
    <role>Study Director</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brooklyn Hospital Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Women's Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3053</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital for Women</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5H 3T9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3P 1R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8S 4J9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 2V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunnybrook &amp; Women's College Health Science Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5S 1B2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Kirpalani H, Whyte RK, Andersen C, Asztalos EV, Heddle N, Blajchman MA, Peliowski A, Rios A, LaCorte M, Connelly R, Barrington K, Roberts RS. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006 Sep;149(3):301-307.</citation>
    <PMID>16939737</PMID>
  </results_reference>
  <results_reference>
    <citation>Whyte RK, Kirpalani H, Asztalos EV, Andersen C, Blajchman M, Heddle N, LaCorte M, Robertson CM, Clarke MC, Vincer MJ, Doyle LW, Roberts RS; PINTOS Study Group. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics. 2009 Jan;123(1):207-13. doi: 10.1542/peds.2008-0338.</citation>
    <PMID>19117884</PMID>
  </results_reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>September 22, 2015</last_update_submitted>
  <last_update_submitted_qc>September 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 24, 2015</last_update_posted>
  <keyword>ELBW premature infants</keyword>
  <keyword>neonatal transfusion</keyword>
  <keyword>bronchopulmonary dysplasia</keyword>
  <keyword>periventricular leukomalacia</keyword>
  <keyword>ventriculomegaly</keyword>
  <keyword>retinopathy of prematurity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

